Machine learning detects early rising behavioral changes in mouse models of Parkinson’s disease

Detecting early rising Parkinson's disease (PD) symptoms could improve treatment outcomes by enabling earlier treatment interventions. In a new eNeuro paper, Daniil Berezhnoi, from Georgetown University, and colleagues used machine learning technology to detect subtle, early rising behavioral changes in mouse models of PD. The researchers also evaluated whether Levodopa, the primary approved treatment for PD, can effectively treat these symptoms. 

Berezhnoi et al. used a previously developed motion sequencing platform to evaluate movements of different mouse models for PD during early stages of disease pathology and during Levodopa treatment. The main advantage of this machine learning platform is that it can automatically detect subsecond postural changes from three-dimensional videos of animals. The researchers discovered that quicker, higher velocity movements were the first affected behaviors in early stages of PD. Levodopa improved movement speed at fine time scales but did not improve other attributes of these movements. 

Speaking on the implications of this work, Berezhnoi says, "Maybe applying the same machine learning approach we used could help identify early biomarkers for Parkinson's in people." 

Source:
Journal reference:

Berezhnoi, D., et al. (2025) Subsecond Analysis of Locomotor Activity in Parkinsonian Mice. eNeurodoi.org/10.1523/ENEURO.0014-25.2025.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Breakthrough soft robotics could redefine artificial heart technology